Silbert

Cassava | Tomorrow - scheduled end of phase IIb | Jackpot?

看多
Silbert 已更新   
NASDAQ:SAVA   Cassava Sciences, Inc.
Is SAVA about to blow up soon? The phase IIb will be most likely done by tomorrow whereby the analysis and evaluation of the results is scheduled for May. So there might be one last pullback before the stock will pulverize the last highs (in case the results are positive!). As a consequence of that I will look for good entries to ride the stock to at least 20$ per share :).
評論:
Launch successful :). The NIH is funding another $2.5 million, which might be a good sign for positive phase 2b results.
評論:
The results aren't published yet, but the expectations grow! The stock is rising sharply :)

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。